AAPL 179.06 +0.32 (+0.18%)MSFT 126.11 +0.03 (+0.02%)FB 181.06 +0.03 (+0.02%)ZNGA 6.06 -0.02 (-0.33%)NVDA 144.95 -0.07 (-0.05%)WBA 51.77 +0.01 (+0.02%)GOOG 1133.33 +0.71 (+0.06%)PIH 5.61 -0.09 (-1.58%)
AAPL 179.06 +0.32 (+0.18%)MSFT 126.11 +0.03 (+0.02%)FB 181.06 +0.03 (+0.02%)ZNGA 6.06 -0.02 (-0.33%)NVDA 144.95 -0.07 (-0.05%)WBA 51.77 +0.01 (+0.02%)GOOG 1133.33 +0.71 (+0.06%)PIH 5.61 -0.09 (-1.58%)

Financial Summary SELB Quote Selecta Bio

Selecta Biosciences Inc. Quote

Selecta Bioscie (SELB)

2.35 0.02 Healthcare
Stock Performance rating :
Recommendation :
Not Available
Symbol SELB
Price 2.35
Beta 1.64
Vol Avg 309.37 K
Mkt cap 52.50 M
Shares 10
Last Div Not Available
Div Yield 0.00%
DCF Unlevered Not Available Not Available
DCF Levered Not Available Not Available
ROE Not Available Not Available
ROA Not Available Not Available
Operating Margin Not Available Not Available
Debt/Equity Not Available Not Available
P/E Not Available Not Available
P/B Not Available Not Available
All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Income Statement
Year 20142015201620172018
Revenue 0 3 6 0 0
COGS 0 0 0 0 0
GrossProfit 0 3 6 8 0
Depreciation (included in COGS) 0 1 1 0 0
StockBasedCompe (included in COGS) 0 1 1 2 4
ResearchAndDeve 0 10 23 30 45
SalesGeneralAnd 0 8 8 13 19
OperatingIncome 0 -15 -25 -35 -64
InterestExpense 0 1 1 1 1
OtherIncome 0 3 1 0 0
IncomeBeforeTax 0 -13 -25 -36 -65
ProvisionForInc 0 0 0 0 0
NetIncome 0 -13 -25 -36 -65
Balance Sheet
Year 20142015201620172018
CashAndCashEqui 0 17 32 59 71
ShortTermInvest 0 0 4 25 26
Cash 0 17 36 0 0
AccountReceivab 0 1 1 0 0
Inventories 0 0 0 0 0
DeferredIncomeT 0 0 0 0 0
OtherCurrentAss 0 1 0 0 0
TotalCurrentAss 0 19 39 87 99
PPE 0 5 5 6 6
AccumulatedDepr 0 -3 -3 -4 -4
NetPPE 0 2 2 2 2
EquityAndOtherI 0 0 0 0 0
Goodwill 0 0 0 0 0
IntangibleAsset 0 0 0 0 0
OtherLTAssets 0 1 2 0 0
TotalNonCurrent 0 3 4 2 2
TotalAssets 0 22 43 89 101
ShortTermDebt 0 3 0 4 0
AccountsPayable 0 0 2 0 0
TaxesPayable 0 0 0 0 0
AccruedLiabilit 0 1 2 0 0
DeferredRevenue 0 3 1 2 1
OtherCurrentLia 0 2 1 2 2
TotalCurrentLia 0 9 7 14 11
Debt 0 5 12 0 0
DeferredTaxesLi 0 0 0 0 0
DeferredRevenue 0 1 2 12 16
OtherLTLiabilit 0 95 138 0 1
TotalNonCurrent 0 101 152 21 38
TotalLiabilitie 0 110 159 34 49
CommonStock 0 0 0 0 0
AdditionalPaidI 0 0 0 211 273
RetainedEarning 0 -84 -112 -152 -217
AccumulatedOthe 0 -4 -5 -5 -4
TotalStockholde 0 -88 -116 55 52
TotalLiabilitie 0 22 43 89 101
Cash Flow Statement
Year 20142015201620172018
NetIncome 0 -13 -25 -36 -65
Depreciation 0 1 1 0 0
DeferredIncomeT 0 0 0 0 0
StockBasedCompe 0 1 1 2 4
AccountsReceiva 0 -1 0 1 0
InventoryCS 0 0 0 0 0
AccountsPayable 0 0 1 3 -2
OtherWorkingCap 0 -1 0 10 3
OtherNonCashIte 0 0 0 0 1
NetCashProvided 0 -13 -22 -20 -52
InvestmentsInPP 0 0 -1 -1 -1
AcquisitionsNet 0 0 0 0 0
PurchasesOfInve 0 0 0 -28 -62
SalesMaturities 0 0 0 0 0
PurchasesOfInta 0 0 0 0 0
OtherInvestingA 0 0 -4 7 60
NetCashUsedForI 0 0 -5 -22 -2
DebtIssued 0 4 14 0 21
DebtRepayment 0 0 -2 0 -13
CommonStockIssu 0 0 0 72 57
CommonStockRepu 0 0 0 0 0
DividendPaid 0 0 0 0 0
OtherFinancingA 0 20 0 -4 1
NetCashProvided 0 25 44 68 66
NetChangeInCash 0 9 16 26 12
CashAtBeginning 0 8 17 32 59
CashAtEndOfPeri 0 17 32 59 71
Retained Earnings
Year 20142015201620172018
RetainedEarning -----84
NetIncome ----13-25
StockDividend ---9753
DividendPaid -----
RetainedEarning ----84-112
Property Plant and Equipment Schedule
Year 20142015201620172018
NetPPE ----2
DeprAnnual 0---3-
CapitalExpendit 00001
NetPPE ---22
Intangible and Goodwill Schedule
Year 20142015201620172018
intAndGW 0----
Amortization 0--2-1
NewPurchases 0---21
intAndGW -----
Company Profile

CEO

Werner Cautreels

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ Global Market

Description

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company using its proprietary synthetic vaccine particle technology to discover & develop targeted therapies designed to modulate the immune system to treat rare and serious diseases.